[Drug resistant malaria].
Kano
Shigeyuki
S
Department of Appropriate Technology Development and Transfer, Research Institute, International Medical Center of Japan.
D000818:Animals; D000962:Antimalarials / Q000008:administration & dosage / Q000494:pharmacology*; D016054:DNA, Protozoan / Q000235:genetics; D004094:Dihydropteroate Synthase / Q000235:genetics; D004351:Drug Resistance / Q000235:genetics; D004359:Drug Therapy, Combination; D019450:Genes, MDR; D006801:Humans; D008288:Malaria / Q000188:drug therapy / Q000469:parasitology*; D010961:Plasmodium / Q000187:drug effects* / Q000235:genetics; D017354:Point Mutation; D015800:Protozoan Proteins
D000962:Antimalarials; C109422:CG2 protein, Plasmodium falciparum; D016054:DNA, Protozoan; D015800:Protozoan Proteins; D004094:Dihydropteroate Synthase